Metformin is also an mTOR inhibitor and promotes the conversion of T helper 17 (Th17) cells to regulatory T (Treg) cells through enhanced autophagic processes [30], suggesting its potential therapeutic application in psoriasis management through the modulation of type 17-mediated inflammation. Here, MTOR is linked to psoriasis.